Professor Nathan Lawrentschuk
Professor Nathan Lawrentschuk
University of Melbourne, Royal Melbourne Hospital, Australia
Verified email at - Homepage
Cited by
Cited by
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised …
MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...
The Lancet 395 (10231), 1208-1216, 2020
Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and …
M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ...
European urology 70 (6), 926-937, 2016
Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution …
M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ...
European urology 77 (4), 403-417, 2020
The role of focal therapy in the management of localised prostate cancer: a systematic review
M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ...
European urology 66 (4), 732-751, 2014
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
ED Crawford, A Heidenreich, N Lawrentschuk, B Tombal, ACL Pompeo, ...
Prostate cancer and prostatic diseases 22 (1), 24-38, 2019
Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial
S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ...
European urology 74 (4), 455-462, 2018
Prevention and management of complications following radical cystectomy for bladder cancer
N Lawrentschuk, R Colombo, OW Hakenberg, SP Lerner, W Månsson, ...
European urology 57 (6), 983-1001, 2010
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ...
BJU international 114 (3), 384-388, 2014
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies
LM Cher, C Murone, N Lawrentschuk, S Ramdave, A Papenfuss, ...
Journal of Nuclear Medicine 47 (3), 410-418, 2006
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the …
L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ...
European urology 80 (6), 682-689, 2021
‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging
N Lawrentschuk, MA Haider, N Daljeet, A Evans, A Toi, A Finelli, ...
BJU international 105 (9), 1231-1236, 2010
The social media revolution is changing the conference experience: analytics and trends from eight international meetings
SE Wilkinson, MY Basto, G Perovic, N Lawrentschuk, DG Murphy
BJU international 115 (5), 839-846, 2015
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ...
BJU international 112, 6-20, 2013
Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study
D Margel, SA Yap, N Lawrentschuk, L Klotz, M Haider, K Hersey, A Finelli, ...
The Journal of urology 187 (4), 1247-1252, 2012
68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
J Corfield, M Perera, D Bolton, N Lawrentschuk
World journal of urology 36, 519-527, 2018
Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy
U Lindner, N Lawrentschuk, RA Weersink, SRH Davidson, O Raz, ...
European urology 57 (6), 1111-1114, 2010
Functional imaging of intratumoral hypoxia
SS Foo, DF Abbott, N Lawrentschuk, AM Scott
Molecular Imaging & Biology 6 (5), 291-305, 2004
Transperineal biopsy of the prostate—is this the future?
DTS Chang, B Challacombe, N Lawrentschuk
Nature Reviews Urology 10 (12), 690-702, 2013
Nutraceuticals and prostate cancer prevention: a current review
G Trottier, PJ Boström, N Lawrentschuk, NE Fleshner
Nature Reviews Urology 7 (1), 21-30, 2010
Landmarks in prostate cancer
NJ Sathianathen, BR Konety, J Crook, F Saad, N Lawrentschuk
Nature Reviews Urology 15 (10), 627-642, 2018
The system can't perform the operation now. Try again later.
Articles 1–20